Category Archives: TB

CDC U.S., global TB data highlight worldwide needs for extended screening, preventive treatment, access to newest medicines

By on .

Releasing the most recent domestic and global data on tuberculosis incidence in this week’s Morbidity and Mortality Weekly Report, the U.S. Centers for Disease Control and Prevention emphasized that while rates of new cases continue to drop, they are not declining swiftly enough to reach important and achievable goals. Those goals include ones agreed to […]

WHO finalizes MDR-TB treatment guidance recommending shift from injections

By on .

Including recommendations that injected drugs with permanent debilitating side effects not be included in longer treatment regimens against multidrug-resistant tuberculosis, and the inclusion of the most recently added drugs, bedaquiline and delamanid in those treatments, the World Health Organization today released updated guidelines for treating TB that does not respond to first line treatments. The […]

STREAM Trial: Nine-month regimen for drug-resistant tuberculosis brings “promising cure rates”

By on .

A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the World Health Organization in 2011 guidelines, substantiates earlier observed findings showing comparable success rates between the two. The STREAM trial (Standard Treatment Regimen of Anti-Tuberculosis drugs for patients with […]

WHO releases updated drug-resistant TB guidelines, removing toxic injectables from recommended treatments

By on .

With the release of a “pre-final text” of updated guidelines for treatment of multidrug- and rifampicin-resistant tuberculosis, the World Health Organization made official substantial changes to its recommendations that the agency first announced in August. The changes, announced in a “rapid communication,” which the WHO said was intended to give TB programs time to plan for […]

World TB Day 2016: CDC’s Shannon Hader on leadership against an epidemic

By on .

The following is a guest post from the U.S. Centers for Disease Control and Prevention Division of Global HIV and TB, with answers to questions on the global tuberculosis pandemic and responses from Division Director Shannon Hader. TB is one of the world’s oldest diseases, yet it continues to kill millions of people each year. […]

As WHO TB report shows 3 million undiagnosed and cites drug-resistance “public health crisis,” physicians urge Obama to increase funding

By on .

Three million people sick with tuberculosis go undiagnosed each year, while failures to address strains of disease that don’t respond to drugs constitute a public health crisis, according to the World Health Organization’s just released 2013 Global Tuberculosis Report. While the report cites progress in continued drops in TB incidence and deaths, it emphasizes that […]

WHO Bulletin review of TB and illicit drug use calls for five “urgent measures”

By on .

Sharing drug equipment that includes water pipes, often living in close quarters, frequently imprisoned, and facing greater than average rates of other health conditions including alcoholism, hepatitis B and C, as well as HIV, people who use illicit drugs have higher than average odds of getting tuberculosis infection and disease, with outbreaks of drug-resistant strains […]

Programs, research, funding for tuberculosis response leave children behind

By on .

When a disease spreads among people living in close quarters and poverty, the question of how hard it is hitting some of the most vulnerable people in its path seems obvious: How many children are suffering from, and dying of tuberculosis? The answer: Nobody seems to know. Numbers are just the tip of the iceberg […]

Global Fund TB allocation shows need for work, action, groups say

By on .

When the Global Fund Board released its September meeting “decision points” document on funding allocation methods, it was, watchers noted, a part of a piece of a work in progress. But one decision will hold for the next year, and will impact efforts to roll out advances in tuberculosis diagnosis and treatment — the decision […]